Ad is loading...
ACLX
Price
$90.44
Change
+$3.22 (+3.69%)
Updated
Nov 22 closing price
116 days until earnings call
KYMR
Price
$44.98
Change
+$1.47 (+3.38%)
Updated
Nov 22 closing price
88 days until earnings call
Ad is loading...

ACLX vs KYMR

Header iconACLX vs KYMR Comparison
Open Charts ACLX vs KYMRBanner chart's image
Arcellx
Price$90.44
Change+$3.22 (+3.69%)
Volume$348.81K
CapitalizationN/A
Kymera Therapeutics
Price$44.98
Change+$1.47 (+3.38%)
Volume$559.36K
CapitalizationN/A
ACLX vs KYMR Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACLX vs. KYMR commentary
Nov 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and KYMR is a StrongBuy.

COMPARISON
Comparison
Nov 24, 2024
Stock price -- (ACLX: $90.44 vs. KYMR: $44.98)
Brand notoriety: ACLX and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 60% vs. KYMR: 128%
Market capitalization -- ACLX: $4.89B vs. KYMR: $2.91B
ACLX [@Biotechnology] is valued at $4.89B. KYMR’s [@Biotechnology] market capitalization is $2.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $468.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACLX and KYMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 5 bearish.
  • KYMR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а +2.97% price change this week, while KYMR (@Biotechnology) price change was +7.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

KYMR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.89B) has a higher market cap than KYMR($2.91B). KYMR YTD gains are higher at: 76.669 vs. ACLX (62.955). ACLX has higher annual earnings (EBITDA): -33.12M vs. KYMR (-160.96M). ACLX (574M) and KYMR (550M) have equal amount of cash in the bank . ACLX has less debt than KYMR: ACLX (65.3M) vs KYMR (88.2M). ACLX has higher revenues than KYMR: ACLX (156M) vs KYMR (87.6M).
ACLXKYMRACLX / KYMR
Capitalization4.89B2.91B168%
EBITDA-33.12M-160.96M21%
Gain YTD62.95576.66982%
P/E RatioN/AN/A-
Revenue156M87.6M178%
Total Cash574M550M104%
Total Debt65.3M88.2M74%
TECHNICAL ANALYSIS
Technical Analysis
ACLXKYMR
RSI
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 14 days ago
89%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NDVTX20.550.34
+1.68%
MFS New Discovery Value R3
CRIMX26.530.34
+1.30%
CRM Mid Cap Value Instl
PYVSX19.900.16
+0.81%
Payden Equity Income SI
MPEYX10.090.04
+0.40%
MassMutual Strat Emerg Mkts Svc
CAIBX72.700.28
+0.39%
American Funds Capital Income Bldr A

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with BEAM. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+3.69%
BEAM - ACLX
51%
Loosely correlated
+6.23%
CRSP - ACLX
48%
Loosely correlated
+3.43%
RCKT - ACLX
48%
Loosely correlated
+10.32%
ALEC - ACLX
47%
Loosely correlated
+4.79%
RCUS - ACLX
47%
Loosely correlated
+2.94%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with VERV. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then VERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+3.38%
VERV - KYMR
50%
Loosely correlated
+5.43%
RXRX - KYMR
47%
Loosely correlated
-0.87%
PRTA - KYMR
47%
Loosely correlated
+1.11%
RVMD - KYMR
46%
Loosely correlated
-0.05%
ACLX - KYMR
46%
Loosely correlated
+3.69%
More